NASDAQ: NBIXNeurocrine Biosciences Inc Stock Ownership - Who owns Neurocrine Biosciences?
Insider buying vs selling
Have Neurocrine Biosciences Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Eiry Roberts | Chief Medical Officer | 2025-02-14 | 500 | $115.04 | $57.52kSell |
| Darin Lippoldt | Chief Legal Officer | 2025-02-13 | 1,086 | $116.75 | $126.79kSell |
| Darin Lippoldt | Chief Legal Officer | 2025-02-13 | 1,098 | $116.76 | $128.20kSell |
| Stephen A. Sherwin | Director | 2025-02-13 | 13,831 | $116.69 | $1.61MSell |
| Julie Cooke | Chief Human Resources Officer | 2025-02-13 | 796 | $116.77 | $92.95kSell |
| Kevin Charles Gorman | Director | 2025-02-13 | 3,012 | $116.68 | $351.45kSell |
| Ingrid Delaet | Chief Regulatory Officer | 2025-02-13 | 716 | $116.69 | $83.55kSell |
| Jude Onyia | Chief Scientific Officer | 2025-02-13 | 1,447 | $116.75 | $168.93kSell |
| Ingrid Delaet | Chief Regulatory Officer | 2025-02-13 | 755 | $116.72 | $88.12kSell |
| Matt Abernethy | Chief Financial Officer | 2025-02-13 | 1,352 | $116.85 | $157.98kSell |
NBIX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when NBIX insiders and whales buy or sell their stock.
NBIX Shareholders
What type of owners hold Neurocrine Biosciences Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Bvf Partners L P | 35.16% | 35,058,600 | $3.55B | Insider |
| Blackrock Inc | 14.83% | 14,782,722 | $1.50B | Institution |
| Vanguard Group Inc | 10.15% | 10,119,641 | $1.03B | Institution |
| State Street Corp | 4.91% | 4,891,137 | $495.86M | Institution |
| Dodge Cox | 3.03% | 3,016,425 | $305.81M | Institution |
| Citadel Advisors LLC | 2.55% | 2,538,109 | $257.31M | Institution |
| Renaissance Technologies LLC | 2.50% | 2,489,397 | $252.38M | Institution |
| Aqr Capital Management LLC | 1.90% | 1,896,891 | $192.31M | Institution |
| Geode Capital Management LLC | 1.88% | 1,875,062 | $190.09M | Institution |
| Bellevue Group Ag | 1.83% | 1,820,000 | $184.51M | Institution |
NBIX vs Pharmaceutical Stocks
Neurocrine Biosciences Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.